Brain Tumor Treatments: Michigan
Sponsored By
Please Click On The Above Banner For More Details
Braintumor Website

Search Term: Michigan
Please scroll down to see the matching trials.

  (0.8169)   Brain Tumor Treatments: Michigan
  (0.7742)   RSR-13
  (0.7742)   Brain Tumor Activism
  (0.7742)   Letter Writing Wizard
  (0.7742)   Brain Tumor Activism
  (0.7742)   Medulloblastoma
  (0.7742)   Untitled Document
  (0.7742)   Brain Tumor Survivor Stories
  (0.7742)   RSR-13
  (0.7742)   RSR-13

Sorry - There were no pages found that contain that search phrase.



  Treatment Location Last Updated
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Detroit, MI USA 07/03/2008
Details A Phase II/III Randomized Study of CDX-110 With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Saginaw, MI USA 07/03/2008
Details A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma Detroit, MI USA 06/28/2008
Details A Phase II Open-Label, Multiple-Dose Study of Intracavitary Administered 131I-TM-601 in Adult Patients with Recurrent High-Grade Glioma Grand Rapids, MI USA 06/28/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Detroit, MI USA 04/11/2008
Details Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma Royal Oak, MI USA 04/11/2008
Details Phase II Trial of Dasatinib in Patients With Recurrent Glioblastoma Multiforme Kalamazoo, MI USA 04/11/2008
Details NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 Detroit, MI USA 03/01/2008
Details A Phase II Trial of Erlotinib (OSI-774) and Sorafenib (BAY 43-9006) for Patients With Progression or Recurrent Glioblastoma Multiforme Detroit, MI USA 08/26/2007
Details A Phase I, Open Label Study of AT-101 (Gossypol) Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients With Newly-Diagnosed Glioblastoma Multiforme Detroit, MI USA 08/19/2007
Details A Phase I Imaging and Safety Study of Intravenous 131-I-TM-601 Labelled Chlorotoxin In Patients with Recurrent or Refractory Somatic and/or Cereberal Metastatic Solid Tumors Grand Rapids, MI USA 06/04/2007
Details Phase I/II Study of Intravenous Infusion of Tetra-o-Methyl Nordihydroguaiaretic Acid (EM-1421) in Subjects With Recurrent High Grade Glioma Detroit, MI USA 05/01/2007
Details Phase I and II, Open-Label, Multi-Center Trials of Pazopanib in Combination With Lapatinib in Adult Patients With Relapsed Malignant Glioma Detroit, MI USA 05/01/2007
Details Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma Detroit, MI USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Detroit, MI USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Kalamazoo, MI USA 05/01/2007
Details A Phase II Study of a Temozolomide-Based Chemoradiotherapy Regimen for High-Risk Low-Grade Gliomas Lambertville, MI USA 05/01/2007
Details Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients With Brain Metastases Secondary to Non-Small Cell Lung Cancer Kalamazoo, MI USA 05/01/2007
Details Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Detroit, MI USA 05/01/2007
Details Sorafenib in Treating Patients With Recurrent or Progressive Malignant Glioma Detroit, MI USA 05/01/2007
Details Talampanel, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Detroit, MI USA 04/29/2007
Details Phase II Trial of Talampanel in Conjunction With Radiation Therapy With Recurrent and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme Detroit, MI USA 04/29/2007
Details Phase II Pilot Study of Adjuvant Radiotherapy and Temozolomide Followed By Temozolomide and Lomustine in Pediatric Patients With Newly Diagnosed High-Grade Gliomas Grand Rapids, MI USA 04/29/2007
Details A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma Detroit, MI USA 04/28/2007
Details Study of a Drug [DCVax®-Brain] to Treat Newly Diagnosed GBM Brain Cancer Detroit, MI USA 01/23/2007
Details A Phase 2 Multicenter Study of AQ4N in Combination With Radiotherapy and Temozolomide, for Safety, Tolerability, and Activity in Subjects With Newly Diagnosed Glioblastoma Multiforme Detroit, MI USA 11/05/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Royal Oak, MI USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Kalamazoo, MI USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Detroit, MI USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Grand Rapids, MI USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Ann Arbor, MI USA 10/12/2006
Details Comprehensive Genetic Analysis Of Brain Tumors In Children. (A Non-Therapeutic Study) Royal Oak, MI USA 10/12/2006
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Lambertville, MI USA 06/26/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Kalamazoo, MI USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Grand Rapids, MI USA 05/30/2006
Details Phase I/II Study of Topotecan, Filgrastim (G-CSF), and Radiotherapy in Young Patients With Newly Diagnosed Malignant Intrinsic Pontine Brain Stem Glioma Detroit, MI USA 05/30/2006
Details PEG-Interferon alfa-2b With or Without Thalidomide in Treating Patients With Recurrent High-Grade Gliomas Ann Arbor, MI USA 05/04/2006
Details Iodine I 131 Monoclonal Antibody TNT-1/B (131I MOAB TNT-1/B), in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Detroit, MI USA 02/03/2006
Details Phase I/II Study of Concurrent Dose Escalation Temodar and Whole Brain Radiation Therapy in Patients with Multiple Brain Metastases. Detroit, MI USA 02/03/2006
Details Phase II Study Utilizing Focal Radiation in Patients with 1-3 Brain Metastases. Detroit, MI USA 02/03/2006
Details Cilengitide (EMD 121974) for Recurrent Glioblastoma Multiforme (Brain Tumor) Detroit, MI USA 02/03/2006
Details Cilengitide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Detroit, MI USA 02/03/2006
Details Phase I Dose Escalation Study of Gliadel in Adults with Recurrent Malignant Gliomas Detroit, MI USA 12/03/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Lansing, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Kalamazoo, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Detroit, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Grand Rapids, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Flint, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Ann Arbor, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Detroit, MI USA 11/27/2005
Details Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma Royal Oak, MI USA 11/27/2005
Details Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma Lambertville, MI USA 11/27/2005
Details A Randomized Phase II Study of Peg-Interferon Alpha-2B (Peg-Intron) Alone or in Combination with Thalidomide in Adults with Recurrent High-Grade Gliomas Ann Arbor, MI USA 11/27/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Lansing, MI USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Detroit, MI USA 11/26/2005
Details Phase II Study of Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiotherapy With or Without Peripheral Blood Stem Cell Rescue in Patients With Intracranial Non-Germinomatous Germ Cell Tumors Detroit, MI USA 11/26/2005
Details Phase I Study of Tipifarnib and Radiotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Ann Arbor, MI USA 11/06/2005
Details Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment Grand Rapids, MI USA 11/06/2005
Details A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy Grand Rapids, MI USA 11/06/2005
Details A Phase II Study of HLA-Matched Peripheral Blood Stem Cell Transplantation for Metastatic Renal Cell Carcinoma as Adoptive Allogeneic Immunotherapy Kalamazoo, MI USA 11/06/2005



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Chat | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Gliadel® Wafer | Temodar®
Fundraising For Research | Unsubscribe | Feedback | Doctors Address Book

IF YOU ARE USING A SCREEN READER, CLICK HERE

Copyright (c) 1993 - 2008 by The Musella Foundation

Website Design By
World Wide Websites